PL325170A1 - Bipolar forms of throwaflocacin - Google Patents

Bipolar forms of throwaflocacin

Info

Publication number
PL325170A1
PL325170A1 PL96325170A PL32517096A PL325170A1 PL 325170 A1 PL325170 A1 PL 325170A1 PL 96325170 A PL96325170 A PL 96325170A PL 32517096 A PL32517096 A PL 32517096A PL 325170 A1 PL325170 A1 PL 325170A1
Authority
PL
Poland
Prior art keywords
throwaflocacin
bipolar forms
bipolar
forms
Prior art date
Application number
PL96325170A
Other languages
English (en)
Inventor
Douglas John Meldrum Allen
David Bruning Joseph
Timothy Norris
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of PL325170A1 publication Critical patent/PL325170A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Physical Water Treatments (AREA)
  • Processing Of Solid Wastes (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
PL96325170A 1995-08-29 1996-07-29 Bipolar forms of throwaflocacin PL325170A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US297595P 1995-08-29 1995-08-29

Publications (1)

Publication Number Publication Date
PL325170A1 true PL325170A1 (en) 1998-07-06

Family

ID=21703460

Family Applications (1)

Application Number Title Priority Date Filing Date
PL96325170A PL325170A1 (en) 1995-08-29 1996-07-29 Bipolar forms of throwaflocacin

Country Status (30)

Country Link
EP (1) EP0850060A1 (fr)
JP (1) JP3188476B2 (fr)
KR (1) KR100343909B1 (fr)
CN (1) CN1190889A (fr)
AP (1) AP636A (fr)
AR (1) AR003985A1 (fr)
AU (1) AU704115B2 (fr)
BR (1) BR9609998A (fr)
CA (1) CA2229786C (fr)
CO (1) CO4480739A1 (fr)
CZ (1) CZ56698A3 (fr)
DZ (1) DZ2087A1 (fr)
GT (1) GT199600072A (fr)
HR (1) HRP960395B1 (fr)
HU (1) HUP9900170A3 (fr)
IL (1) IL122651A (fr)
MA (1) MA23966A1 (fr)
MY (1) MY113874A (fr)
NO (1) NO309814B1 (fr)
NZ (1) NZ312199A (fr)
OA (1) OA10669A (fr)
PE (1) PE12598A1 (fr)
PL (1) PL325170A1 (fr)
RU (1) RU2144921C1 (fr)
SK (1) SK23898A3 (fr)
TN (1) TNSN96109A1 (fr)
TR (1) TR199800339T1 (fr)
WO (1) WO1997007800A1 (fr)
YU (1) YU48396A (fr)
ZA (1) ZA967282B (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HN1998000106A (es) 1997-08-01 1999-01-08 Pfizer Prod Inc Composiciones parenterales de alatroflaxacino
US7019142B2 (en) 1998-01-16 2006-03-28 Pfizer Inc. Process for preparing naphthyridones and intermediates
PA8466701A1 (es) * 1998-01-21 2000-09-29 Pfizer Prod Inc Comprimido de mesilato de trovafloxacino
US6114531A (en) * 1998-07-28 2000-09-05 Pfizer Inc. Process for preparing quinolone and naphthyridone carboxylic acids
HN1999000141A (es) * 1998-09-03 2000-06-19 Pfizer Prod Inc Procedimiento para preparar sales de trovafloxacina de adicion de acidos.
US6239141B1 (en) * 1999-06-04 2001-05-29 Pfizer Inc. Trovafloxacin oral suspensions

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5164402A (en) * 1989-08-16 1992-11-17 Pfizer Inc Azabicyclo quinolone and naphthyridinone carboxylic acids

Also Published As

Publication number Publication date
BR9609998A (pt) 1999-07-06
AU6367696A (en) 1997-03-19
AP9600853A0 (en) 1996-10-31
CZ56698A3 (cs) 1999-02-17
CO4480739A1 (es) 1997-07-09
AP636A (en) 1998-04-09
AR003985A1 (es) 1998-09-30
NZ312199A (en) 1999-06-29
IL122651A (en) 2000-02-17
PE12598A1 (es) 1998-03-20
MA23966A1 (fr) 1997-04-01
GT199600072A (es) 1998-02-14
YU48396A (sh) 1998-12-23
RU2144921C1 (ru) 2000-01-27
JPH10511692A (ja) 1998-11-10
NO980862D0 (no) 1998-02-27
MX9801664A (es) 1998-08-30
EP0850060A1 (fr) 1998-07-01
CN1190889A (zh) 1998-08-19
MY113874A (en) 2002-06-29
TR199800339T1 (xx) 1998-06-22
HUP9900170A2 (hu) 1999-05-28
IL122651A0 (en) 1998-08-16
ZA967282B (en) 1998-03-02
JP3188476B2 (ja) 2001-07-16
NO309814B1 (no) 2001-04-02
OA10669A (en) 2000-11-06
WO1997007800A1 (fr) 1997-03-06
HUP9900170A3 (en) 1999-11-29
AU704115B2 (en) 1999-04-15
CA2229786C (fr) 2002-02-19
CA2229786A1 (fr) 1997-03-06
DZ2087A1 (fr) 2002-07-22
NO980862L (no) 1998-02-27
SK23898A3 (en) 1999-05-07
TNSN96109A1 (fr) 2005-03-15
HRP960395B1 (en) 2001-12-31
HRP960395A2 (en) 1998-06-30
KR19990044232A (ko) 1999-06-25
KR100343909B1 (ko) 2003-04-10

Similar Documents

Publication Publication Date Title
PL322277A1 (en) Derivatives of pyrazol-4-ylobenzoyl
GB9715519D0 (en) Variety of different sources
GB9526560D0 (en) Use of 2-Amino-Heterocycles
GB9505169D0 (en) Waveform
PL324451A1 (en) Derivatives of diphenylmethylenepiperidine
GB9512290D0 (en) Uses of polyhexanide
IL116924A0 (en) Preparation of n-aryl- and n-hetarylhydroxylamines
SG42329A1 (en) Use of phenylcyclohexylcarboxamides
PL326080A1 (en) Short forms of chemokin beta-8
CY2590B2 (en) Preparation of 1-butyl-4-piperidinylmethylamine
PL325170A1 (en) Bipolar forms of throwaflocacin
IL117786A (en) Preparation of alpha-bisoximes
HUT76555A (en) Derivatives of trans apovincaminic-acid-esters
ZA968873B (en) Isomerisation of equillin
NZ295530A (en) Preparation of 1-halo-3-trialkylsilanyl-benzenes
ZA963825B (en) Composition of matter
PL313849A1 (en) Beta-aminoesters of o-hydrobenzylamides
ZA962440B (en) Destressing of railtracks
CA76199S (en) Set of dishes
SG64924A1 (en) Inhibiting photodecompostion of 3-substituted-2- oxindoles
PL103664U1 (en) Set of desks
GB9503734D0 (en) Manufacture of polyanlines
GB9514072D0 (en) Preparation of thionucleosides
HRP950468A2 (en) New medicine - combination of components
PL311980A1 (en) Open-profile shape of double-z type